NADH- and N2-oxidation in hydrogen bacteria studied by respiratory chain inhibitors.
D000968:Antimycin A / Q000494:pharmacology; D003352:Corynebacterium / Q000201:enzymology / Q000378:metabolism*; D003580:Cytochromes / Q000378:metabolism; D004112:Dimercaprol / Q000494:pharmacology; D004579:Electron Transport / Q000187:drug effects; D005420:Flavoproteins / Q000378:metabolism; D006859:Hydrogen / Q000378:metabolism*; D007659:Ketones / Q000494:pharmacology; D008365:Manometry; D009243:NAD / Q000378:metabolism*; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010101:Oxygen Consumption; D011549:Pseudomonas / Q000201:enzymology / Q000378:metabolism*; D011804:Quinolines / Q000494:pharmacology; D012402:Rotenone / Q000494:pharmacology; D013053:Spectrophotometry; D013447:Sulfites
D003580:Cytochromes; D005420:Flavoproteins; D007659:Ketones; D011804:Quinolines; D013447:Sulfites; D012402:Rotenone; D004112:Dimercaprol; D009243:NAD; D000968:Antimycin A; D006859:Hydrogen; D010088:Oxidoreductases